Forecast

There is no analyst data available for this company.

News Go to news feed

Monash IVF faces sharp share decline after second embryo mix-up

Monash IVF Group shares have dropped 25% following a second embryo mix-up this year, intensifying concerns over reputational damage and regulatory scrutiny. Despite these setbacks, the company remains a major player in the fertility sector, with strong fundamentals and ongoing expansion in Southeast Asia. Some investors see the current low share price as a potential value opportunity if the company can restore trust and stabilize sentiment. » More on themarketonline.com.au

Historical dividends Dividends

All dividend metrics All metrics

In 2026, Monash IVF Group has already paid €0.00723 in dividends. The last payout was in April.

Financials

In the last quarter, Monash IVF Group had revenue of €78.38M and net profit of €4.07M

(EUR)	Dec 2025	YoY
Revenue	78.38M	-
Gross profit	18.96M	-
Net profit	4.07M	-
EBITDA	15.38M	-

Fundamentals

Metric	Value
Market capitalization	€168.6M
Number of shares	389.63M
52-week high/low	€0.55 - €0.36
Dividend yield	1.72%
Dividends TTM	€0.00723
Beta	0.38
P/E ratio	17.99
PEG ratio	0.03
P/B ratio	1.07
P/S ratio	1.01

Company profile

Die Monash IVF Group Limited erbringt Dienstleistungen im Bereich der assistierten Reproduktion und der Bildgebung für Frauen in Australien und Malaysia. Das Unternehmen bietet diagnostische geburtshilfliche und gynäkologische Ultraschalluntersuchungen sowie Forschungs- und Behandlungsdienstleistungen im Bereich der Fruchtbarkeit an. Es bietet auch pränatale Diagnostik und IVF-Behandlung auf Tertiärniveau an. Die Monash IVF Group Limited wurde 2014 gegründet und hat ihren Sitz in Richmond, Australien.